Literature DB >> 31446212

Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.

Ping Yuan1, Sha Huang2, Fei-Chao Bao3, Jin-Lin Cao2, Hong-Xu Sheng2, Liang Shi4, Wang Lv2, Jian Hu5.   

Abstract

BACKGROUND: The role of epidermal growth factor receptor (EGFR) pathways in regulating telomerase is increasingly being recognised. We analysed the impact of rs2853669 single nucleotide polymorphism (SNP) on telomere parameters and its prognostic value for non-small cell lung cancer (NSCLC) with or without EGFR mutation.
METHODS: The association of rs2853669 with telomerase reverse transcriptase (TERT) mRNA level and relative telomere length (RTL) was analysed using resected tumour samples from 250 NSCLC patients. We also investigated the patients' clinical outcomes with a median follow-up of 57 months (2-99 months).
RESULTS: The rs2853669 T/C allele was significantly associated with lower TERT mRNA expression (versus C/C and versus T/T; p < 0.001 for both) and shorter RTL (versus C/C and versus T/T; p = 0.039 and 0.023) in patients without EGFR mutation. Such difference was not observed in their counterparts harbouring EGFR mutation. When considering the cohort as a whole, T/C allele was significantly associated with shortest overall survival compared with T/T or C/C allele (mean: 61.8, 80.9 and 88.7 months, plog-rank < 0.001) and disease-free survival (mean: 78.3, 87.9 and 91.5 months, plog-rank = 0.019). Stratification analyses showed that the negative prognostic effect of T/C on OS was constrained in patients without EGFR mutation.
CONCLUSION: Our study revealed significant associations of a common SNP within TERT promoter region on telomere parameters and survival in NSCLC patients without EGFR mutation. The result may help providing instruction for therapeutic interventions targeting telomerase and evidence for investigation of TERT-EGFR interacting mechanism in telomere biology.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidermal growth factor receptor mutation (EGFR); Non-small cell lung cancer (NSCLC); Survival outcome; Telomerase reverse transcriptase (TERT); Telomere length; rs2853669 single-nucleotide polymorphism (rs2853669 SNP)

Mesh:

Substances:

Year:  2019        PMID: 31446212     DOI: 10.1016/j.ejca.2019.06.024

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  2 in total

Review 1.  Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.

Authors:  Md Abdul Aziz; Sarah Jafrin; Mohammad Safiqul Islam
Journal:  Hum Cell       Date:  2021-03-20       Impact factor: 4.174

2.  [Clinical Application and Challenges of Telomere and Telomerase Research 
in Lung Cancer].

Authors:  Sen Han; Xu Ma; Jian Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.